Inflammatory markers and long term hematotoxicity of holmium-166-radioembolization in liver-dominant metastatic neuroendocrine tumors after initial peptide receptor radionuclide therapy

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2191-219X

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Inflammatory markers and long term hematotoxicity of holmium-166-radioembolization in liver-dominant metastatic neuroendocrine tumors after initial peptide receptor radionuclide therapy ; volume:12 ; number:1 ; day:2 ; month:2 ; year:2022 ; pages:1-13 ; date:12.2022
EJNMMI Research ; 12, Heft 1 (2.2.2022), 1-13, 12.2022

Creator: Ebbers, Sander C.
Brabander, Tessa
Tesselaar, Margot E. T.
Hofland, Johannes
Braat, Manon N. G. J. A.
Wessels, Frank J.
Barentsz, Maarten W.
Lam, Marnix G. E. H.
Braat, Arthur J. A. T.

Contributor: SpringerLink (Online service)

DOI: 10.1186/s13550-022-00880-4

URN: urn:nbn:de:101:1-2022051119534211362433

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:23 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Ebbers, Sander C.
Brabander, Tessa
Tesselaar, Margot E. T.
Hofland, Johannes
Braat, Manon N. G. J. A.
Wessels, Frank J.
Barentsz, Maarten W.
Lam, Marnix G. E. H.
Braat, Arthur J. A. T.
SpringerLink (Online service)

Other Objects (12)

Holmium-166 Radioembolization: Current Status and Future Prospective

Radioembolization for Metastatic Neuroendocrine Tumors

Radioembolization with 90Y Resin Microspheres of Neuroendocrine Liver Metastases After Initial Peptide Receptor Radionuclide Therapy

Automatic healthy liver segmentation for holmium-166 radioembolization dosimetry

Gamma camera characterization at high holmium-166 activity in liver radioembolization

Radionuclide Theranostics in Neuroendocrine Neoplasms: An Update

Quality of life in patients with liver tumors treated with holmium-166 radioembolization

Clinical Results of Holmium-166 Radioembolization with Personalized Dosimetry for the Treatment of Hepatocellular Carcinoma

Holmium-166 Radioembolization of Hepatic Metastases in Salvage Setting: Preliminary Findings from a Single Center Experience

Advances in Radionuclide Therapies for Patients with Neuro-endocrine Tumors

Dose–effect relationships in neuroendocrine tumour liver metastases treated with [166Ho]-radioembolization

Apparent pacemaker dysfunction during peptide receptor radionuclide therapy for neuroendocrine tumor

Holmium-166 Radioembolization: Current Status and Future Prospective

Radioembolization for Metastatic Neuroendocrine Tumors

Radioembolization with 90Y Resin Microspheres of Neuroendocrine Liver Metastases After Initial Peptide Receptor Radionuclide Therapy

Automatic healthy liver segmentation for holmium-166 radioembolization dosimetry

Gamma camera characterization at high holmium-166 activity in liver radioembolization

Radionuclide Theranostics in Neuroendocrine Neoplasms: An Update

Quality of life in patients with liver tumors treated with holmium-166 radioembolization

Clinical Results of Holmium-166 Radioembolization with Personalized Dosimetry for the Treatment of Hepatocellular Carcinoma

Holmium-166 Radioembolization of Hepatic Metastases in Salvage Setting: Preliminary Findings from a Single Center Experience

Advances in Radionuclide Therapies for Patients with Neuro-endocrine Tumors

Dose–effect relationships in neuroendocrine tumour liver metastases treated with [166Ho]-radioembolization

Apparent pacemaker dysfunction during peptide receptor radionuclide therapy for neuroendocrine tumor

Holmium-166 Radioembolization: Current Status and Future Prospective

Radioembolization for Metastatic Neuroendocrine Tumors

Radioembolization with 90Y Resin Microspheres of Neuroendocrine Liver Metastases After Initial Peptide Receptor Radionuclide Therapy

Automatic healthy liver segmentation for holmium-166 radioembolization dosimetry

Gamma camera characterization at high holmium-166 activity in liver radioembolization

Radionuclide Theranostics in Neuroendocrine Neoplasms: An Update

Quality of life in patients with liver tumors treated with holmium-166 radioembolization

Clinical Results of Holmium-166 Radioembolization with Personalized Dosimetry for the Treatment of Hepatocellular Carcinoma

Holmium-166 Radioembolization of Hepatic Metastases in Salvage Setting: Preliminary Findings from a Single Center Experience

Advances in Radionuclide Therapies for Patients with Neuro-endocrine Tumors

Dose–effect relationships in neuroendocrine tumour liver metastases treated with [166Ho]-radioembolization

Apparent pacemaker dysfunction during peptide receptor radionuclide therapy for neuroendocrine tumor

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Inflammatory markers and long term hematotoxicity of holmium-166-radioembolization in liver-dominant metastatic neuroendocrine tumors after initial peptide receptor radionuclide therapy

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Holmium-166 Radioembolization: Current Status and Future Prospective

Radioembolization for Metastatic Neuroendocrine Tumors

Radioembolization with 90Y Resin Microspheres of Neuroendocrine Liver Metastases After Initial Peptide Receptor Radionuclide Therapy

Automatic healthy liver segmentation for holmium-166 radioembolization dosimetry

Gamma camera characterization at high holmium-166 activity in liver radioembolization

Radionuclide Theranostics in Neuroendocrine Neoplasms: An Update

Quality of life in patients with liver tumors treated with holmium-166 radioembolization

Clinical Results of Holmium-166 Radioembolization with Personalized Dosimetry for the Treatment of Hepatocellular Carcinoma

Holmium-166 Radioembolization of Hepatic Metastases in Salvage Setting: Preliminary Findings from a Single Center Experience

Advances in Radionuclide Therapies for Patients with Neuro-endocrine Tumors

Dose–effect relationships in neuroendocrine tumour liver metastases treated with [166Ho]-radioembolization

Apparent pacemaker dysfunction during peptide receptor radionuclide therapy for neuroendocrine tumor

Holmium-166 Radioembolization: Current Status and Future Prospective

Radioembolization for Metastatic Neuroendocrine Tumors

Radioembolization with 90Y Resin Microspheres of Neuroendocrine Liver Metastases After Initial Peptide Receptor Radionuclide Therapy

Automatic healthy liver segmentation for holmium-166 radioembolization dosimetry

Gamma camera characterization at high holmium-166 activity in liver radioembolization

Radionuclide Theranostics in Neuroendocrine Neoplasms: An Update

Quality of life in patients with liver tumors treated with holmium-166 radioembolization

Clinical Results of Holmium-166 Radioembolization with Personalized Dosimetry for the Treatment of Hepatocellular Carcinoma

Holmium-166 Radioembolization of Hepatic Metastases in Salvage Setting: Preliminary Findings from a Single Center Experience

Advances in Radionuclide Therapies for Patients with Neuro-endocrine Tumors

Dose–effect relationships in neuroendocrine tumour liver metastases treated with [166Ho]-radioembolization

Apparent pacemaker dysfunction during peptide receptor radionuclide therapy for neuroendocrine tumor

Holmium-166 Radioembolization: Current Status and Future Prospective

Radioembolization for Metastatic Neuroendocrine Tumors

Radioembolization with 90Y Resin Microspheres of Neuroendocrine Liver Metastases After Initial Peptide Receptor Radionuclide Therapy

Automatic healthy liver segmentation for holmium-166 radioembolization dosimetry

Gamma camera characterization at high holmium-166 activity in liver radioembolization

Radionuclide Theranostics in Neuroendocrine Neoplasms: An Update

Quality of life in patients with liver tumors treated with holmium-166 radioembolization

Clinical Results of Holmium-166 Radioembolization with Personalized Dosimetry for the Treatment of Hepatocellular Carcinoma

Holmium-166 Radioembolization of Hepatic Metastases in Salvage Setting: Preliminary Findings from a Single Center Experience

Advances in Radionuclide Therapies for Patients with Neuro-endocrine Tumors

Dose–effect relationships in neuroendocrine tumour liver metastases treated with [166Ho]-radioembolization

Apparent pacemaker dysfunction during peptide receptor radionuclide therapy for neuroendocrine tumor

Related objects

Reset password